194-OR: Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Older Adults (≥70 Years) with Type 2 Diabetes (T2DM): A Subgroup Analysis of the ATOS Study

ATOS was a 12-month prospective observational study in 18 countries outside US and Western Europe in insulin-naïve adults with T2DM, uncontrolled (HbA1c >7-≤11%) on ≥1 oral anti-hyperglycemic drug. This subgroup analysis of ATOS compared the effectiveness and safety of Gla-300 in older (≥70 years...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser:	GALSTYAN, GAGIK R., TIROSH, AMIR, VARGAS-URICOECHEA, HERNANDO, MABUNAY, MARIA AILEEN N., COUDERT, MATHIEU, PILORGET, VALERIE, KHAN, NIAZ
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Clinical outcomes Diabetes Diabetes mellitus (non-insulin dependent) Hypoglycemia Insulin Older people
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!